Dimensional Fund Advisors
CLYM

Dimensional Fund Advisors’s Climb Bio CLYM Stock Holding History

Dimensional Fund Advisors’s Portfolio CLYM Stock Details CLYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.12M Buy
239,451
+135,014
+129% +$1.39M ﹤0.01% 2634
2026
Q1 		$715K Buy
+104,437
New +$602K ﹤0.01% 2898
2024
Q4 		– Sell
-18,280
Closed -$93K – 3370
2024
Q3 		$93K Buy
18,280
+5,720
+46% +$40.5K ﹤0.01% 3247
2024
Q2 		$89.3K Buy
+12,560
New +$83.6K ﹤0.01% 3260

Other funds holding CLYM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors's CLYM Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Climb Bio (CLYM) stake by 129% in Q2 2026, buying an estimated $1.39M and bringing the position to 239,451 shares worth $3.12M. The position accounts for ﹤0.01% of the portfolio, ranked #2634.

Dimensional Fund Advisors first reported a position in CLYM in Q2 2024 and has held it in 4 quarters since. 109 funds tracked by Wall St. Rank hold CLYM as of Q2 2026.

  • Dimensional Fund Advisors held 239,451 shares of Climb Bio worth $3.12M as of Q2 2026.
  • Dimensional Fund Advisors bought 135,014 Climb Bio shares in Q2 2026, an estimated $1.39M.
  • Climb Bio made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2634 holding.
  • Dimensional Fund Advisors first reported a position in Climb Bio in Q2 2024 and has held it in 4 quarters since.
  • 109 funds tracked by Wall St. Rank held Climb Bio as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.